SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-023537
Filing Date
2021-07-06
Accepted
2021-07-06 17:49:37
Documents
2
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1421
2 EXHIBIT 24 brhc10026625_ex24.htm EX-24 9131
  Complete submission text file 0001140361-21-023537.txt   12218
Mailing Address 10 FINDERNE AVENUE BRIDGEWATER NJ 08807
Business Address
Pellizzari Christine A (Reporting) CIK: 0001127430 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35890 | Film No.: 211075394

Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations